Related by context. All words. (Click for frequent words.) 81 comorbidities 74 comorbid conditions 74 comorbid 70 psychiatric comorbidity 69 multivariate analyzes 68 psychiatric comorbidities 67 covariate 67 logistic regression model 67 MetS 67 MMSE score 67 covariates 67 prognostic factors 66 depressive symptomatology 66 sociodemographic characteristics 66 psychiatric morbidity 66 co morbidities 66 preoperative PSA 66 sociodemographic variables 66 multivariate analysis 65 univariate analyzes 65 chronicity 65 sociodemographic factors 65 comorbid depression 65 HRQL 65 HRQoL 65 HRQOL 65 logistic regression analysis 65 subclinical atherosclerosis 65 nonadherence 65 univariate analysis 65 comorbid disorders 64 multivariable analysis 64 familial aggregation 64 carotid IMT 64 logistic regression analyzes 64 alexithymia 64 affective psychoses 64 autonomic dysfunction 64 depressive symptoms 64 confounding variables 64 univariate 64 sociodemographic 64 affective disorders 63 Comorbidity 63 carotid stenosis 63 dysthymia 63 Charlson comorbidity index 63 % CI #.#-#.# [006] 63 syndromal 63 subclinical hypothyroidism 63 LUTS 63 multivariable analyzes 63 confounders 63 affective psychosis 63 unipolar depression 63 APOE genotype 63 comorbid anxiety 62 confidence intervals CIs 62 perioperative complications 62 CVD mortality 62 biochemical recurrence 62 nodal metastases 62 QoL 62 confounder 62 neurocognitive function 62 premorbid 62 nonfatal MI 62 logistic regression models 62 symptom severity 62 multivariate logistic regression 62 euthymic patients 62 Logistic regression analysis 62 bivariate 62 androgen deficiency 62 unmeasured confounders 62 comorbid illnesses 62 somatoform disorders 62 somatic symptoms 62 comorbid psychiatric 62 Subgroup analyzes 61 abdominal adiposity 61 T2DM 61 Charlson Comorbidity Index 61 postoperative mortality 61 noncardiac 61 EQ 5D 61 hypertension diabetes mellitus 61 MMSE scores 61 prognostic variables 61 psychosocial functioning 61 affective disorder 61 diabetes mellitus DM 61 atherothrombotic disease 61 suicide attempters 61 BMI z 61 psychopathology 61 IPAH 61 coronary artery calcification 61 nondepressed 61 Cognitive impairment 61 prostate cancer CaP 61 Comorbid 61 neurocognitive impairment 61 advanced neoplasia 61 postoperative complication 61 logistic regression 61 Depressive symptoms 61 potentially modifiable 61 confidence interval #.#-#.# 61 obstructive coronary artery 61 elevated CRP 61 cardiovascular mortality 61 subclinical hyperthyroidism 61 microalbuminuria 61 thyrotropin levels 61 radical prostatectomy RP 61 coronary artery calcium 61 underdiagnosis 61 Multivariate analysis 61 nonfasting triglyceride levels 60 pretest probability 60 posttreatment 60 symptomatology 60 mammographic density 60 Univariate analysis 60 platelet reactivity 60 nonpsychiatric 60 NIHSS score 60 psychiatric diagnoses 60 obstructive CAD 60 neurocognitive deficits 60 subscore 60 multivariate Cox 60 familial clustering 60 psychosocial variables 60 lymph node involvement 60 postoperative AF 60 schizophreniform disorder 60 Univariate 60 Sociodemographic 60 thromboembolic 60 nondiabetic patients 60 tumor histology 60 neurocognitive functioning 60 depressive symptom 60 Multivariate analyzes 60 depressive disorders 60 beta blocker therapy 60 Logistic regression 60 acetabular dysplasia 59 oncologic outcomes 59 postoperative complications 59 CHD mortality 59 psychiatric disorders 59 oxygen desaturation 59 HRCT 59 NAFLD 59 morbidity 59 morbidities 59 SLNB 59 colorectal neoplasia 59 adenotonsillectomy 59 MGUS 59 macrovascular disease 59 contralateral breast cancer 59 generalizability 59 prognostic indicators 59 CORE OM 59 intraobserver 59 HIV HCV coinfected 59 interobserver 59 % CI #.#-#.# [007] 59 LV dysfunction 59 residual confounding 59 hippocampal volume 59 coinfected patients 59 polygenic 59 postdischarge 59 conditional logistic regression 59 potential confounders 59 comorbid diagnoses 59 prevalences 59 cerebral infarction 59 bulimia nervosa 59 periprocedural MI 59 meta regression 59 shorter telomere length 59 Socioeconomic status 59 androgen deprivation 59 bivariate analyzes 59 metabolic parameters 59 subsyndromal 59 nephron sparing surgery 59 subscales 59 hip BMD 59 nonpsychotic 59 PCa 59 β blockers 59 Prehypertension 59 NIHSS 59 adiposity 59 SCr 58 Kaplan Meier analysis 58 perioperative mortality 58 multivariate adjustment 58 TT genotype 58 thrombophilia 58 Poisson regression 58 sd = 58 etiologic 58 untreated psychosis 58 coronary stenosis 58 atypical hyperplasia 58 cranial irradiation 58 coronary calcium 58 #q#.# deletion syndrome 58 clinicopathological 58 PSADT 58 cerebral microbleeds 58 MACCE 58 autistic traits 58 subtrochanteric 58 CI = 58 euthymic 58 gallstone disease 58 P = .# 58 probands 58 somatization disorder 58 preoperative chemotherapy 58 highest tertile 58 tertiles 58 CLBP 58 confidence interval CI 58 nonoperative treatment 58 adenomatous polyps 58 lymph node metastasis 58 postoperative pulmonary 58 subscale scores 58 neuropsychological functioning 58 Comorbidities 58 socio demographic 58 unfavorable prognostic 58 p = .# [002] 58 preoperative 58 socioeconomic status 58 hippocampal volumes 58 endophenotypes 58 atherogenic dyslipidemia 58 primary aldosteronism 58 allele frequencies 58 pCR 58 diabetes mellitus hypertension 58 % CI #.#-#.# [008] 58 plasma homocysteine 58 TEAEs 58 syndromic 58 periprocedural 58 hippocampal atrophy 58 coronary calcification 58 Montgomery Åsberg Depression 58 antenatal depression 58 systolic dysfunction 58 extrapyramidal symptoms 58 Operative mortality 58 biopsy Gleason 58 carotid intima media 58 postintervention 58 substance induced psychosis 58 subgroup analyzes 58 neoplastic 58 CaP 58 regression analyzes 57 nonalcoholic steatohepatitis NASH 57 serum PSA 57 preoperative diagnosis 57 atherothrombotic 57 bivariate analysis 57 genetic polymorphisms 57 APOE ε4 57 neurological abnormalities 57 neurologic complications 57 thromboembolism 57 dysthymic disorder 57 histologically confirmed 57 pathologic 57 PSQI 57 white matter hyperintensities 57 highly heritable 57 pT3 57 clinicopathologic 57 interrater reliability 57 vertebral fracture 57 demographic variables 57 carotid atherosclerosis 57 socioeconomic variables 57 nonobese 57 definite stent thrombosis 57 modifiable risk 57 explanatory variables 57 suicidal ideation 57 Observational studies 57 Neuroticism 57 BMI ≥ 57 extensive metabolizers 57 posttransplant 57 #q# deletion syndrome 57 lymph node metastases 57 androgen suppression 57 aetiology 57 inflammatory biomarkers 57 prognostic significance 57 intima media thickness 57 adverse perinatal 57 poststroke 57 MADRS score 57 angiographically 57 psychotic disorders 57 Rating Scale BPRS 57 endometrial thickness 57 SRBD 57 renal artery stenosis 57 psychopathological symptoms 57 HbA 1c levels 57 APACHE II 57 penetrance 57 retrospective cohort study 57 multivariable adjusted 57 symptomatic VTE 57 clinicopathological features 57 APOE e4 57 somatoform disorder 57 EGFR mutation status 57 Index CDAI 57 NNT = 57 ELBW infants 57 Main Outcome Measures 57 Genetic variants 57 pT2 57 microbleeds 57 Heritability 57 prognostic factor 57 hypochondriasis 57 acute cholecystitis 57 serum estradiol 57 puerperal psychosis 57 WOMAC pain 57 % CI #.#-#.# [005] 57 df = 57 CC genotype 57 elevated LDH 57 psychiatric disorder 57 lowest tertile 57 impaired glucose metabolism 57 renal dysfunction 57 borderline personality disorder 57 adnexal mass 57 fragility fracture 57 schizophrenia schizoaffective disorder 57 proband 57 hypoxemia 57 stepwise logistic regression 57 hypovitaminosis D 57 rs# [003] 57 SGAs 57 postoperative delirium 57 interobserver reliability 57 thyroid nodules 57 % CI #.#-#.# [004] 57 undergoing CABG 57 lipid lowering agents 57 CI #.#-#.# [001] 57 myocardial infarction MI 57 neuropsychological assessment 56 β = 56 VUR 56 aortic calcification 56 albumin excretion 56 serum cotinine 56 colorectal adenomas 56 extracapsular extension 56 aldosterone antagonist 56 radical nephrectomy 56 hallux valgus 56 EuroSCORE 56 arterial thromboembolic events 56 body fatness 56 atherothrombosis 56 multivessel disease 56 Y BOCS 56 HF hospitalization 56 generalized estimating 56 AUDs 56 prospective cohort 56 % CI #.#-#.# [003] 56 T1a 56 perinatal outcomes 56 adrenalectomy 56 subclinical 56 lipid abnormalities 56 T1c 56 comorbid substance 56 dyslipidaemia 56 Suicidal ideation 56 rheumatoid factor 56 waist circumference WC 56 spirometric 56 behavioral disinhibition 56 5 HTTLPR 56 liver transplant recipients 56 SUVmax 56 parkinsonism 56 lymphadenectomy 56 neurodevelopmental impairment 56 metabolic abnormalities 56 Klinefelter syndrome 56 baseline LDH 56 SGRQ 56 hyperglycaemia 56 plain radiographs 56 subclinical disease 56 advanced adenoma 56 colorectal adenoma 56 glycated hemoglobin levels 56 silent myocardial ischemia 56 extracolonic findings 56 Postoperative 56 meta analytic 56 chronic pancreatitis 56 perioperative morbidity 56 baseline HbA1c 56 poorer prognosis 56 adjuvant therapies 56 amnestic MCI 56 venous thrombosis 56 Coronary artery calcium 56 reinfarction 56 confounding factors 56 Bonferroni correction 56 multivariable logistic regression 56 HNSCC 56 hematopoietic cancers 56 asthma exacerbations 56 mood disorders 56 rs# [004] 56 rs# [002] 56 subthreshold depression 56 virological response 56 causal pathway 56 hypercoagulable 56 LV ejection fraction 56 intact parathyroid hormone 56 laterality 56 ICD implantation 56 CYP#D# genotype 56 postoperative infections 56 postoperative radiotherapy 56 left ventricular hypertrophy 56 paroxysmal AF 56 DSM IV diagnosis 56 ipsilateral stroke 56 cognitive affective 56 ischemic lesions 56 adjuvant chemotherapy 56 intracranial stenosis 56 serum creatinine levels 56 gestational diabetes mellitus 56 dichotomized 56 node metastases 56 Brief Psychiatric 56 chronic renal insufficiency 56 suicide ideation 56 interpersonal psychotherapy 56 F FDG PET 56 convergent validity 56 postoperative atrial fibrillation 56 echocardiographic parameters 56 EBRT 56 asthma exacerbation 56 polyp recurrence 56 MDRD equation 56 coexisting illnesses 56 diabetes mellitus 56 prospectively defined 56 CIN2 + 56 stratifying patients 56 coronary revascularization 56 impaired cognition 56 DSM IV Axis 56 unmeasured confounding 56 intracerebral haemorrhage 56 CHADS2 56 venous thromboembolic disease 56 advanced adenomas 56 histologic subtype 56 morphometric vertebral fractures 56 NNRTI resistance 56 albuminuria 56 PSA velocity 56 % CI #.#-#.# [002] 56 arteriography 56 cardiometabolic risk 56 clinically localized prostate 56 postmenopausal hormone 55 multifactorial 55 underlying pathophysiology 55 histological subtype 55 de ath 55 urolithiasis 55 Socio demographic 55 preoperatively 55 adenoma recurrence 55 thromboembolic complications 55 transferrin saturation 55 knee OA 55 multiple logistic regression 55 recurrent DVT 55 seminal vesicle invasion 55 monoclonal gammopathy 55 unmeasured factors 55 Multiple logistic regression 55 etiology 55 guideline concordant 55 BMD measurements 55 Major depressive disorder 55 predisposing factor 55 pharmacologic treatments 55 asymptomatic carotid stenosis 55 NMIBC 55 pretransplant 55 abnormal lipid 55 overdiagnosis 55 CR nPR 55 incomplete revascularization 55 EDSS score 55 nonpharmacologic 55 ECOG PS 55 Genetic predisposition 55 postop 55 cardiovascular comorbidities 55 undergoing coronary angiography 55 Longitudinal studies 55 schizotypal traits 55 nonfatal myocardial infarction 55 cardioembolic stroke 55 EDSS scores 55 LAGB 55 histologic 55 HSCT 55 BPRS 55 etiological factors 55 VADT 55 rs# [001] 55 hyperhomocysteinemia 55 Complication rates 55 unfavorable cytogenetics 55 venous thromboembolism 55 hydroxyvitamin D levels 55 adjuvant radiotherapy 55 MDRD 55 T1DM 55 recurrent UTI 55 lymphovascular invasion 55 systolic hypertension 55 HbA 1c 55 chlamydial infection 55 artery stenosis 55 FDG PET 55 postoperative morbidity 55 methotrexate monotherapy 55 aetiological 55 hypoglycemic events 55 serum vitamin D 55 plasma cortisol 55 familial predisposition 55 neuropathological 55 somatic complaints 55 nonparametric 55 locoregional recurrence 55 tertile 55 LVNC 55 gene polymorphisms 55 NYHA functional class 55 varicocele 55 neuropsychiatric symptoms 55 familial pancreatic cancer 55 underwent resection 55 biopsychosocial 55 adjunctive ABILIFY 55 DSM IV SCID 55 neovascular glaucoma 55 POAG 55 myocardial infarction stroke 55 adenoidectomy 55 metabolic syndrome 55 left ventricular systolic 55 BRCA2 mutation carriers 55 neuropsychological deficits 55 medication nonadherence 55 mRS 55 HNPCC 55 cognitive impairment 55 COPD exacerbation 55 rebleeding 55 tic severity 55 nonsignificant 55 chorioamnionitis 55 Main Outcome Measure 55 Multivariate analysis revealed 55 index BMI 55 PSA kinetics 55 tHcy 55 genotypic resistance 55 retrospective cohort 55 liver histology 55 abdominal obesity 55 serum PTH 55 OSAHS 55 prespecified secondary 55 Hurthle cell 55 femoral neck fracture 55 renal insufficiency 55 Mood disorders 55 inotropic 55 hypersomnia 55 NIH CPSI 55 recurrent VTE 55 NHANES III 55 left ventricular dysfunction 55 DSM IV 55 PTEN mutations 55 undergoing radical prostatectomy 55 pelvic lymphadenectomy 55 Symptom Checklist 55 psychometric properties 55 odds ratios ORs 55 kidney allograft 55 polyarticular 55 elevated ALT 55 CABG 55 heterozygotes 55 cTnT 55 internalizing disorders 55 DAS# [002] 55 HER2 expression 55 carotid plaque 55 albumin excretion rate 55 Subgroup analysis 55 nulliparous women 55 impaired fasting glucose 55 thiopurine 55 coronary revascularizations 55 arterial stiffness 55 randomized controlled trials RCTs 55 fasting insulin 55 hypercholesterolemia 55 typical antipsychotics 55 osteochondroma 55 BRCA1 mutation carriers 55 prefrontal cortical 54 SLC#A# [002] 54 pathophysiological mechanisms 54 nonvertebral fractures 54 patients undergoing CABG 54 Expanded Disability Status 54 subcortical 54 IL#B 54 serum concentrations 54 pharmacological interventions 54 SE alleles 54 mortality morbidity 54 endosonography 54 STEP BD 54 longitudinal studies 54 morbidity mortality 54 karyotypes 54 % Confidence Interval 54 etiological 54 graft dysfunction 54 recurrent tonsillitis 54 infarcts 54 carotid endarterectomy 54 dose atorvastatin 54 serum calcium 54 perfusion abnormalities 54 hematuria 54 depressive disorder 54 strongest predictors 54 lipid lowering therapy 54 hydroxyvitamin D 54 HbA1c levels 54 GBA mutations 54 carotid bruit 54 hypoperfusion 54 microsatellite instability 54 epididymitis 54 SYNTAX trial 54 dyslipidemia hypertension 54 distant metastasis 54 histopathologic 54 polypharmacy 54 DRD2 54 coronary artery disease 54 cystatin C 54 atypical antipsychotic medications 54 hematologic toxicity 54 fasting glucose levels 54 HAM D# 54 stenoses 54 potentially confounding variables 54 MS DRG 54 susceptibility loci 54 postprocedure 54 cardiovascular disease hypertension 54 operable breast cancer 54 sonographic findings 54 nondiabetic 54 secondary efficacy endpoint 54 neonatal morbidity 54 lower extremity amputation 54 HER2 overexpression 54 myocardial ischemia 54 macroalbuminuria 54 Crohn Disease Activity 54 nomograms 54 covariance 54 neurologic sequelae 54 p = 54 subclinical cardiovascular disease 54 revascularization procedures 54 p = #.# [003] 54 Preoperatively 54 concomitant medications 54 CIN3 54 Predictors 54 Structured Clinical 54 cerebrovascular accident 54 serum folate 54 clinically meaningful reductions 54 dissociative symptoms 54 adenoma 54 sCJD 54 nodal metastasis 54 depressive episode 54 ischemic cardiomyopathy 54 nondemented 54 Endothelial dysfunction 54 predictive validity 54 elevated creatinine 54 #q# deletion 54 rCBF 54 homozygosity 54 CHD CVD 54 electrophysiologic 54 pediatric bipolar disorder 54 HbA1C levels 54 pg ml 54 noncardiovascular mortality 54 MS DRGs 54 non affective psychosis 54 HAMD 54 IBDQ 54 colorectal polyps 54 posttraumatic stress disorder PTSD 54 underwent CABG 54 atheroma volume 54 glucose abnormalities 54 arterial thickening 54 psychiatric outpatients 54 prognostic 54 estimated GFR 54 psychodynamic psychotherapy 54 hemodynamic parameters 54 Recurrence Score 54 airway responsiveness 54 acetabular fractures 54 hypertensives 54 lipid lowering medications 54 GH deficiency 54 Major Depressive Disorder 54 HAQ DI 54 chest radiographs 54 NSTEMI 54 FEV ^ sub 54 hepatorenal syndrome 54 interindividual variability 54 nonfasting triglycerides 54 prothrombotic 54 symptomatic intracerebral hemorrhage 54 metabolic disturbances 54 genomewide 54 mild renal insufficiency 54 myocardial viability 54 plasma creatinine 54 antipsychotic prescribing 54 potential confounding variables 54 atopy 54 Prevalence 54 prodromal 54 asymptomatic PAD 54 dysphoric 54 subscores 54 myocardial infarction 54 femoral neck BMD 54 diabetes dyslipidemia 54 myocardial infarctions 54 BRCA1 mutations 54 heterogeneity 54 Reynolds Risk Score 54 Breslow thickness 54 clinically insignificant 54 posttraumatic 54 Personality disorders 54 baseline FEV 54 nonrandomized 54 PANSS 54 genotype 54 MELD scores 54 HbA 1C 54 estimated glomerular filtration 54 visceral adiposity 54 incidentalomas 54 adverse cytogenetics 54 testicular tumors 54 laboratory abnormalities 54 decrements 54 TAVR 54 spontaneous bacterial peritonitis 54 comorbid psychiatric disorders 54 PSA nadir 54 prostate cancer PCa 54 Coronary artery calcification 54 coronary artery aneurysms 54 osteopenic 54 elevated IOP 54 cognitively intact 54 dysglycemia 54 aminotransferases 54 serum lipid levels 54 antioxidant supplementation 54 specific antigen PSA 54 authors conclude 54 psychological distress 54 nonalcoholic steatohepatitis 54 APOC3 54 post thrombotic syndrome 54 Scale EDSS score 54 supratentorial 54 Postoperative complications 54 NAMCS 54 Stent thrombosis 54 callous unemotional traits 54 bacterial prostatitis 54 bipolar affective disorder 54 ALSFRS R 54 elevated LDL cholesterol 54 multivariable Cox 54 coronary atherosclerosis 54 adiponectin concentrations 54 mammographically 54 tryptophan depletion 54 heritable variation 54 Framingham Offspring Study 54 hyperintensities 54 carotid plaques 54 ANCOVA 54 neuropsychological impairment 54 neoadjuvant 54 salivary cortisol 54 erythrocyte sedimentation rate 54 pharmacologic intervention 54 pericardial effusion 54 somatization 54 severe hypoglycemia 54 Apgar scores 54 FFR measurements 54 socioeconomic status SES 54 oral anticoagulation 54 BRCA carriers 54 lacunar 54 BI RADS 54 pharmacologic interventions 54 macrovascular events 54 Rating Scale MADRS 54 locoregional 54 elevated triglyceride levels 54 microscopic colitis 54 histopathological 54 distant metastases 54 neuroanatomical 54 Multivariate logistic regression 54 residual platelet reactivity 54 XIENCE V PROMUS Stent 54 genotypic 54 dyspnoea 54 hypertension dyslipidemia 54 proton MR spectroscopy 54 inhospital mortality 54 preintervention 54 CI -#.# 54 psychotic illnesses 54 underwent radical prostatectomy 54 lipoprotein levels 54 Sjögren syndrome 54 postoperative chemotherapy 54 cardiorespiratory fitness 54 HOMA IR 54 subthreshold 54 meta analytic review 53 fractional anisotropy 53 BRCA mutation carriers 53 cryptorchidism 53 #F FDG PET 53 RYGB 53 hamartomas 53 lymphocyte count 53 vitamin D inadequacy 53 DAS# scores 53 correlational 53 serum selenium 53 multivariable adjustment 53 hyperkinetic disorder 53 limiting generalizability 53 genotype phenotype 53 perinatal mortality 53 diastolic pressures 53 recurrent venous thromboembolism 53 antihypertensive therapy 53 pulmonary nodules 53 menarche 53 EGFR mutations 53 psychiatric hospitalization 53 hepatic resection 53 LVEF 53 attention-deficit/hyperactivity disorder ADHD 53 genetic loci 53 prepregnancy BMI 53 radiotherapy RT 53 prospective longitudinal 53 airway hyperresponsiveness 53 obese adolescents 53 malperfusion 53 BPH LUTS 53 endometrial carcinoma 53 preterm delivery 53 metabolic syndrome MetS 53 dose Iluvien 53 telomere lengths 53 posttraumatic stress disorder 53 elevated triglycerides 53 vesicoureteral reflux 53 UGT#A# * 53 aortic insufficiency 53 somatostatin analogs 53 Leitzmann 53 Hb A1C 53 treat NNT 53 nonvertebral fracture 53 attention-deficit/hyperactivity disorder 53 central corneal thickness 53 acute myocardial infarction MI 53 aneurysmal subarachnoid hemorrhage 53 2D 4D ratio 53 serum ferritin 53 recurrent miscarriage 53 anti JCV antibodies 53 serum IGF 53 coronary heart 53 antiphospholipid antibodies 53 electroencephalographic 53 cTnT levels 53 KIF6 carriers 53 statin therapy 53 Heterogeneity 53 radiographic findings 53 multivariate adjusted 53 axillary node dissection 53 BMI percentile 53 clinico pathological 53 transvaginal sonography 53 onset diabetes mellitus 53 mIU L 53 intraventricular hemorrhage 53 hsCRP 53 Exclusion criteria 53 hormone receptor status 53 nicotine dependence 53 APOE gene 53 myocardial ischaemia 53 LVSD 53 antiplatelet agents 53 androgen excess 53 #q# [001] 53 cerebrovascular events 53 intraclass correlation coefficients 53 genetic variants associated 53 coronary stenoses 53 postoperative 53 neoplasm 53 waist girth